European Commission approves Roche ' s Hemlibra for people with haemophilia A with inhibitors

Roche today announced that the European Commission has approved Hemlibra ® (emicizumab) for routine prophylaxis of bleeding episodes in people with haemophilia A with factor VIII inhibitors.
Source: Roche Media News - Category: Pharmaceuticals Source Type: news